NCT00003740View on ClinicalTrials.gov

Trastuzumab in Treating Patients With Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1998

Primary Completion Date

September 30, 2002

Study Completion Date

September 30, 2002

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

trastuzumab

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003740 - Trastuzumab in Treating Patients With Prostate Cancer | Biotech Hunter | Biotech Hunter